Session 5: Potential Benefits of GOF Research II: Treatment and Response (*)
Video
24-12-2014
* Artikelen en video's representeren niet noodzakelijkerwijs de opinie van Burgerplatform. Ze worden ter beschikking gesteld ten behoeve van de eigen oordeelsvorming van de bezoeker en interne dialoog.
Baruch Fischhoff moderates a session in which a panel of academic, government and industry representatives discuss how GOF research could potentially benefit the acceleration of vaccine and antiviral development. The panel includes Philip Dormitzer (synthetic influenza vaccine viruses), Ralph Baric (vaccines targeting coronaviruses), Jerry Weir (regulatory perspective on viral manipulation for biologics), and Mark Denison (GOF research and countermeasures against SARS and MERS.)
